FDA Approves Combo of Opdivo Plus Yervoy for Advanced Liver Cancer
2025-04-15
The CheckMate-9DW trial showed significant overall survival benefit versus lenvatinib or sorafenibContinue Reading
In-Hospital Addiction Consultations Put Opioid Users On Path To Recovery
2025-04-15
TUESDAY, April 15, 2025 (HealthDay News) — People hospitalized for opioid use can better fight their addiction if their path to recovery begins in the hospital, a new study says. Opioid users who receive addiction consultation services during their hospital stay are significantly more likely to start taking addiction medsContinue Reading
FDA Announces Plan to Phase Out Some Animal Testing
2025-04-14
New strategy aims to enhance drug safety, expedite evaluation process, and decrease animal experimentationContinue Reading
CDC Urges Extra Measles Shot For Some U.S. Travelers Amid Outbreak
2025-04-11
FRIDAY, April 11, 2025 (HealthDay News) — The U.S. Centers for Disease Control and Prevention (CDC) now recommends extra measles protection for people traveling to areas with active outbreaks in the United States, CBS News reported. In an April 8 letter, the CDC advised health departments that travelers going toContinue Reading
Experimental Drug Can Slow MS Disability
2025-04-09
WEDNESDAY, April 9, 2025 (HealthDay News) — An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called non-relapsing secondaryContinue Reading
FDA Delays Final Approval of Novavax COVID Vaccine
2025-04-04
FRIDAY, April 4, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has delayed the full approval of Novavax’s COVID-19 vaccine. The decision had been expected by April 1, but the agency now says it needs more information before moving forward. The Novavax shot is already available underContinue Reading
Antidepressants Linked To Sudden Cardiac Death
2025-04-04
FRIDAY, April 4, 2025 (HealthDay News) — Antidepressants appear to increase people’s risk of sudden cardiac death, a new study says. People taking the mood meds are more likely to die suddenly from heart problems, and their risk rises the longer they’re on the drugs, according to findings presented MondayContinue Reading
FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia
2025-04-02
Subcutaneous injection cuts the amount of the protein antithrombin, leading to an increase in thrombinContinue Reading
Shingles Vaccine Protects Against Dementia
2025-04-02
TUESDAY, April 2, 2025 (HealthDay News) — The shingles vaccine can do more than protect seniors from painful, blistering rashes. It also appears to protect older folks from dementia, researchers say. Seniors who got the shingles vaccine when it became available in the U.K. were 20% less likely to developContinue Reading
Low ‘Bad’ Cholesterol Might Protect Against Dementia, Alzheimer’s
2025-04-02
WEDNESDAY, April 2, 2025 (HealthDay News) — Lower levels of “bad” LDL cholesterol could mean a lower risk of dementia and Alzheimer’s disease, a new study says. People with low-density lipoprotein (LDL) cholesterol levels lower than 70 mg/dl had a 26% lower risk of dementia and 28% lower risk ofContinue Reading
Experts Concerned as NIH Axes Critical Vaccine Study Funds
2025-04-01
TUESDAY, April 1, 2025 (HealthDay News) — Hundreds of U.S. research projects aimed at boosting vaccine confidence have been shut down — just as preventable diseases like measles and flu are on the rise. Since Jan. 20, the U.S. Department of Health and Human Services (HHS) has canceled more thanContinue Reading
-690x550.jpg)
Local Outbreaks Can Motivate the Vaccine-Hesitant, Poll Finds
2025-03-31
MONDAY, March 31, 2025 (HealthDay News) — COVID-19 and influenza burned through the U.S. during this year’s cold and flu season, and deadly measles outbreaks have sickened people in 19 states. So what does it take to get people vaccinated against these preventable diseases? Essentially, an outbreak within a person’sContinue Reading
FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors
2025-03-31
Patients treated with cabozantinib survived significantly longer with no worsening of their disease compared with patients who received placeboContinue Reading
Top FDA Vaccine Official Quits, Warns of Vaccine Misinformation
2025-03-31
MONDAY, March 31, 2025 (HealthDay News) — A top vaccine official at the U.S. Food and Drug Administration (FDA) is stepping down, warning that vaccine misinformation is coloring the country’s top health decisions. Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said he will resignContinue Reading